FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903768048> ?p ?o ?g. }

• W2903768048 endingPage "622" @default.
• W2903768048 startingPage "612" @default.
• W2903768048 abstract "We reported previously that a synthetic mucosal adjuvant SF-10, which mimics human pulmonary surfactant, delivers antigen to mucosal dendritic cells in the nasal cavity and promotes induction of humoral and cellular immunity. The aim of the present study was to determine the effects of oral administration of antigen combined with SF-10 (antigen-SF-10) on systemic and local immunity. Oral administration of ovalbumin, a model antigen, combined with SF-10 enhanced ovalbumin uptake into intestinal antigen presenting MHC II+CD11c+ cells and their CD11b+CD103+ and CD11b+CD103- subtype dendritic cells, which are the major antigen presenting subsets of the intestinal tract, more efficiently compared to without SF-10. Oral vaccination with influenza hemagglutinin vaccine (HAv)-SF-10 induced HAv-specific IgA and IgG in the serum, and HAv-specific secretory IgA and IgG in bronchoalveolar lavage fluid, nasal washes, gastric extracts and fecal material; their levels were significantly higher than those induced by subcutaneous HAv or intranasal HAv and HAv-SF-10 vaccinations. Enzyme-linked immunospot assay showed high numbers of HAv-specific IgA and IgG antibody secreting cells in the gastrointestinal and respiratory mucosal lymphoid tissues after oral vaccination with HAv-SF-10, but no or very low induction following oral vaccination with HAv alone. Oral vaccination with HAv-SF-10 provided protective immunity against severe influenza A virus infection, which was significantly higher than that induced by HAv combined with cholera toxin. Oral vaccination with HAv-SF-10 was associated with unique cytokine production patterns in the spleen after HAv stimulation; including marked induction of HAv-responsive Th17 cytokines (e.g., IL-17A and IL-22), high induction of Th1 cytokines (e.g., IL-2 and IFN-γ) and moderate induction of Th2 cytokines (e.g., IL-4 and IL-5). These results indicate that oral vaccination with HAv-SF-10 induces more efficient systemic and local immunity than nasal or subcutaneous vaccination with characteristically high levels of secretory HAv-specific IgA in various mucosal organs and protective immunity." @default.
• W2903768048 created "2018-12-22" @default.
• W2903768048 creator A5011235497 @default.
• W2903768048 creator A5028201702 @default.
• W2903768048 creator A5039271899 @default.
• W2903768048 creator A5042754568 @default.
• W2903768048 creator A5087962680 @default.
• W2903768048 date "2019-01-01" @default.
• W2903768048 modified "2023-10-18" @default.
• W2903768048 title "Oral vaccination with influenza hemagglutinin combined with human pulmonary surfactant-mimicking synthetic adjuvant SF-10 induces efficient local and systemic immunity compared with nasal and subcutaneous vaccination and provides protective immunity in mice" @default.
• W2903768048 cites W1535176917 @default.
• W2903768048 cites W1964693476 @default.
• W2903768048 cites W1984669065 @default.
• W2903768048 cites W1986760417 @default.
• W2903768048 cites W2001194497 @default.
• W2903768048 cites W2002392006 @default.
• W2903768048 cites W2011888594 @default.
• W2903768048 cites W2014012487 @default.
• W2903768048 cites W2014373251 @default.
• W2903768048 cites W2023107945 @default.
• W2903768048 cites W2029131536 @default.
• W2903768048 cites W2040957336 @default.
• W2903768048 cites W2052509247 @default.
• W2903768048 cites W2055986053 @default.
• W2903768048 cites W2060687200 @default.
• W2903768048 cites W2063950598 @default.
• W2903768048 cites W2072237100 @default.
• W2903768048 cites W2073625279 @default.
• W2903768048 cites W2083824233 @default.
• W2903768048 cites W2093591024 @default.
• W2903768048 cites W2094807194 @default.
• W2903768048 cites W2095336525 @default.
• W2903768048 cites W2097216581 @default.
• W2903768048 cites W2101305676 @default.
• W2903768048 cites W2107235439 @default.
• W2903768048 cites W2110957620 @default.
• W2903768048 cites W2115430090 @default.
• W2903768048 cites W2119351286 @default.
• W2903768048 cites W2128359705 @default.
• W2903768048 cites W2149766747 @default.
• W2903768048 cites W2161956066 @default.
• W2903768048 cites W2166454467 @default.
• W2903768048 cites W2267205758 @default.
• W2903768048 cites W2295679183 @default.
• W2903768048 cites W2409517212 @default.
• W2903768048 cites W2593653145 @default.
• W2903768048 cites W2608273632 @default.
• W2903768048 cites W273531563 @default.
• W2903768048 cites W2779698349 @default.
• W2903768048 cites W2787612809 @default.
• W2903768048 cites W629881574 @default.
• W2903768048 doi "https://doi.org/10.1016/j.vaccine.2018.12.002" @default.
• W2903768048 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30553569" @default.
• W2903768048 hasPublicationYear "2019" @default.
• W2903768048 type Work @default.
• W2903768048 sameAs 2903768048 @default.
• W2903768048 citedByCount "10" @default.
• W2903768048 countsByYear W29037680482019 @default.
• W2903768048 countsByYear W29037680482020 @default.
• W2903768048 countsByYear W29037680482021 @default.
• W2903768048 countsByYear W29037680482022 @default.
• W2903768048 countsByYear W29037680482023 @default.
• W2903768048 crossrefType "journal-article" @default.
• W2903768048 hasAuthorship W2903768048A5011235497 @default.
• W2903768048 hasAuthorship W2903768048A5028201702 @default.
• W2903768048 hasAuthorship W2903768048A5039271899 @default.
• W2903768048 hasAuthorship W2903768048A5042754568 @default.
• W2903768048 hasAuthorship W2903768048A5087962680 @default.
• W2903768048 hasBestOaLocation W29037680481 @default.
• W2903768048 hasConcept C147483822 @default.
• W2903768048 hasConcept C203014093 @default.
• W2903768048 hasConcept C22070199 @default.
• W2903768048 hasConcept C2776090121 @default.
• W2903768048 hasConcept C2776946954 @default.
• W2903768048 hasConcept C2777863537 @default.
• W2903768048 hasConcept C2779053233 @default.
• W2903768048 hasConcept C71924100 @default.
• W2903768048 hasConcept C8891405 @default.
• W2903768048 hasConceptScore W2903768048C147483822 @default.
• W2903768048 hasConceptScore W2903768048C203014093 @default.
• W2903768048 hasConceptScore W2903768048C22070199 @default.
• W2903768048 hasConceptScore W2903768048C2776090121 @default.
• W2903768048 hasConceptScore W2903768048C2776946954 @default.
• W2903768048 hasConceptScore W2903768048C2777863537 @default.
• W2903768048 hasConceptScore W2903768048C2779053233 @default.
• W2903768048 hasConceptScore W2903768048C71924100 @default.
• W2903768048 hasConceptScore W2903768048C8891405 @default.
• W2903768048 hasFunder F4320311405 @default.
• W2903768048 hasIssue "4" @default.
• W2903768048 hasLocation W29037680481 @default.
• W2903768048 hasLocation W29037680482 @default.
• W2903768048 hasOpenAccess W2903768048 @default.
• W2903768048 hasPrimaryLocation W29037680481 @default.
• W2903768048 hasRelatedWork W1983325185 @default.
• W2903768048 hasRelatedWork W2033998433 @default.
• W2903768048 hasRelatedWork W2093242067 @default.
• W2903768048 hasRelatedWork W2220102944 @default.
• W2903768048 hasRelatedWork W2736540239 @default.

• next